12/2
07:02 am
vtyx
Ventyx Provides Clinical and Corporate Updates
High
Report
Ventyx Provides Clinical and Corporate Updates
12/1
07:02 am
vtyx
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/17
07:02 am
vtyx
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
Low
Report
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
11/11
05:14 pm
vtyx
Ventyx Biosciences: Why Caution Should Remain [Seeking Alpha]
Medium
Report
Ventyx Biosciences: Why Caution Should Remain [Seeking Alpha]
11/7
05:36 pm
vtyx
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $14.00 to $16.00. They now have a "buy" rating on the stock.
11/7
02:22 pm
vtyx
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Wells Fargo & Company from $11.00 to $14.00. They now have an "overweight" rating on the stock.
Low
Report
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Wells Fargo & Company from $11.00 to $14.00. They now have an "overweight" rating on the stock.
11/6
11:33 pm
vtyx
Ventyx Biosciences GAAP EPS of -$0.32 [Seeking Alpha]
Low
Report
Ventyx Biosciences GAAP EPS of -$0.32 [Seeking Alpha]
11/6
04:02 pm
vtyx
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
Medium
Report
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress
11/5
07:19 am
vtyx
Ventyx Biosciences (NASDAQ:VTYX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
Medium
Report
Ventyx Biosciences (NASDAQ:VTYX) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
10/27
08:57 am
vtyx
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $9.00 to $14.00. They now have an "outperform" rating on the stock.
Medium
Report
Ventyx Biosciences (NASDAQ:VTYX) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $9.00 to $14.00. They now have an "outperform" rating on the stock.
10/26
12:25 am
vtyx
Ventyx Biosciences (VTYX) Rethinks Anti-Inflammatory Pipeline After Promising Phase 2 Results for VTX3232 [Yahoo! Finance]
Medium
Report
Ventyx Biosciences (VTYX) Rethinks Anti-Inflammatory Pipeline After Promising Phase 2 Results for VTX3232 [Yahoo! Finance]
10/22
04:02 pm
vtyx
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors
High
Report
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors